Developer docs
API playgroundTry for free, no card

Search company profiles

Qlarity Imaging

Full company profile

uuid000ldgc

Namestring
Qlarity Imaging
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Qlarity Imaging is a Chicago-based, privately held company founded in 2019 that states its mission as offering AI to improve patient care by enhancing diagnostic insights available to radiologists. The company is very small (1-10 employees) and is led by founder Jeff Aronin and CTO Jim Buswell, with no additional management, advisory, or research staff disclosed. Its stated core capability is artificial intelligence applied to radiology, though no specific products, model architecture, training data, clinical validation, or regulatory pathway (e.g., FDA 510(k)) are disclosed in available sources.

The company's commercial footprint is minimal. Its primary domain, qlarityimaging.com, is currently parked with TierraNet and displays a reserved-page notice, indicating no active website, product surface, customer portal, or marketing presence. There is no publicly disclosed pricing model, distribution channel, GTM motion, revenue, funding history, ownership structure, headcount detail, partnerships, awards, or certifications in the available data. The company does not appear in the profiled vendor lists of recent Software-as-a-Medical Device market analyses, suggesting limited or no commercial traction.

Given the absence of disclosed products, customers, revenue, or funding, the operating posture as of the available data is best characterized as an early-stage, pre-commercial entity that has not yet launched a market-facing offering. Investor-relevant signals — burn rate, capital raised, validation studies, regulatory filings, key hires beyond the CTO — are all missing, representing a material diligence gap.

Short descriptiontext

Qlarity Imaging is a Chicago-based, privately held startup founded in 2019 that states it builds AI to enhance diagnostic insights for radiologists. The company has 1-10 employees, a parked website, and no disclosed products, customers, or revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
radiology AI software, medical imaging diagnostics, AI diagnostic imaging, radiologist decision support, clinical imaging software
Industry4 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code3 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services54151
  • Custom Computer Programming Services541511
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Computer Programming Services7371
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
Product category
Medical Imaging Software
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Qlarity Imaging develops artificial intelligence software aimed at improving patient care by enhancing the diagnostic insights available to radiologists. The company's offering centers on AI-driven analysis of medical images to support radiology workflows and clinical decision-making.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Qlarity Imaging operates a parked domain at qlarityimaging.com. No active product, service, or company information is available from the provided sources.

Product and service1 record
1AI Diagnostic Imaging Software
CategoryMedical Imaging Software
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Aidoc develops AI-powered clinical decision support for radiologists, with FDA-cleared algorithms across CT and triage workflows — a direct, more mature competitor in the radiology AI category where Qlarity Imaging operates.

TypeDirect peer
Description

Viz.ai applies AI to neuroimaging workflows (notably stroke detection) and communicates findings directly to specialists, directly comparable to Qlarity Imaging's stated radiology AI focus.

3Zebra Medical Vision (Nanox AI)
TypeDirect peer
Description

Zebra Medical Vision / Nanox AI develops AI algorithms for radiology image interpretation across multiple modalities, directly competing in the same radiology AI / CAD software category.

TypeDirect peer
Description

Riverain Technologies provides AI-powered chest X-ray and CT clarity enhancement tools for radiologists, directly comparable to Qlarity Imaging's "enhancing diagnostic insights" positioning.

TypeDirect peer
Description

Blackford Analysis offers an AI platform and curated algorithm marketplace for radiology, overlapping with Qlarity Imaging's radiology AI orchestration and inference category.

TypeDirect peer
Description

Arterys, now part of Tempus, pioneered cloud-native medical imaging AI with FDA-cleared algorithms for cardiac and chest imaging — directly comparable in product and regulatory pathway to Qlarity Imaging.

TypeEmerging player
Description

iCAD develops AI-based image analysis for breast cancer detection and therapy planning, an adjacent radiology AI application sharing similar technology and customer base with Qlarity Imaging.

TypeBroad incumbent
Description

GE HealthCare's Edison platform bundles radiology AI capabilities with its installed base of imaging equipment and PACS, representing the broad incumbent that competes with and often acquires smaller radiology AI vendors.

TypeBroad incumbent
Description

Philips offers IntelliSpace AI and a portfolio of clinically validated radiology algorithms integrated into its imaging and PACS ecosystem, a broad incumbent peer with overlapping capability in AI-enhanced radiology workflows.

TypeBroad incumbent
Description

Siemens Healthineers' AI-Rad Companion offers AI-driven image analysis across multiple modalities integrated with their imaging fleet, representing a broad incumbent that competes in the same radiology AI segment.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qlarity Imaging

Medical Imaging Softwareqlarityimaging.com

Qlarity Imaging is a Chicago-based, privately held startup founded in 2019 that states it builds AI to enhance diagnostic insights for radiologists. The company has 1-10 employees, a parked website, and no disclosed products, customers, or revenue.

What Qlarity Imaging does

Qlarity Imaging is a Chicago-based, privately held company founded in 2019 that states its mission as offering AI to improve patient care by enhancing diagnostic insights available to radiologists. The company is very small (1-10 employees) and is led by founder Jeff Aronin and CTO Jim Buswell, with no additional management, advisory, or research staff disclosed. Its stated core capability is artificial intelligence applied to radiology, though no specific products, model architecture, training data, clinical validation, or regulatory pathway (e.g., FDA 510(k)) are disclosed in available sources.

The company's commercial footprint is minimal. Its primary domain, qlarityimaging.com, is currently parked with TierraNet and displays a reserved-page notice, indicating no active website, product surface, customer portal, or marketing presence. There is no publicly disclosed pricing model, distribution channel, GTM motion, revenue, funding history, ownership structure, headcount detail, partnerships, awards, or certifications in the available data. The company does not appear in the profiled vendor lists of recent Software-as-a-Medical Device market analyses, suggesting limited or no commercial traction.

Given the absence of disclosed products, customers, revenue, or funding, the operating posture as of the available data is best characterized as an early-stage, pre-commercial entity that has not yet launched a market-facing offering. Investor-relevant signals — burn rate, capital raised, validation studies, regulatory filings, key hires beyond the CTO — are all missing, representing a material diligence gap.

Qlarity Imaging firmographics

Firmographics
Name
Qlarity Imaging
Website
https://qlarityimaging.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Qlarity Imaging is a Chicago-based, privately held startup founded in 2019 that states it builds AI to enhance diagnostic insights for radiologists. The company has 1-10 employees, a parked website, and no disclosed products, customers, or revenue.
Ownership category
akta.pro rank

Qlarity Imaging industry classification

Industry
Product category
Medical Imaging Software
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Computer Programming Services (7371), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Radiology AI software
  • Medical imaging diagnostics
  • AI diagnostic imaging
  • Radiologist decision support
  • Clinical imaging software

Where Qlarity Imaging is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Markets served

Qlarity Imaging business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Qlarity Imaging product offering

Product offering

Core offering

Qlarity Imaging develops artificial intelligence software aimed at improving patient care by enhancing the diagnostic insights available to radiologists. The company's offering centers on AI-driven analysis of medical images to support radiology workflows and clinical decision-making.

Product overview

Qlarity Imaging operates a parked domain at qlarityimaging.com. No active product, service, or company information is available from the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI Diagnostic Imaging Software

Companies that use Qlarity Imaging

Customer profile

Ideal customer profiles1 record

Qlarity Imaging technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Qlarity Imaging partnerships and signals

Strategic signal

Recent moves3 records

Qlarity Imaging competitors and assessment

Company assessment

Direct peers

  • Aidoc: Aidoc develops AI-powered clinical decision support for radiologists, with FDA-cleared algorithms across CT and triage workflows — a direct, more mature competitor in the radiology AI category where Qlarity Imaging operates.
  • Viz.ai: Viz.ai applies AI to neuroimaging workflows (notably stroke detection) and communicates findings directly to specialists, directly comparable to Qlarity Imaging's stated radiology AI focus.
  • Zebra Medical Vision (Nanox AI): Zebra Medical Vision / Nanox AI develops AI algorithms for radiology image interpretation across multiple modalities, directly competing in the same radiology AI / CAD software category.
  • Riverain Technologies: Riverain Technologies provides AI-powered chest X-ray and CT clarity enhancement tools for radiologists, directly comparable to Qlarity Imaging's "enhancing diagnostic insights" positioning.
  • Blackford Analysis: Blackford Analysis offers an AI platform and curated algorithm marketplace for radiology, overlapping with Qlarity Imaging's radiology AI orchestration and inference category.
  • Arterys (Tempus): Arterys, now part of Tempus, pioneered cloud-native medical imaging AI with FDA-cleared algorithms for cardiac and chest imaging — directly comparable in product and regulatory pathway to Qlarity Imaging.

Emerging players

  • iCAD: iCAD develops AI-based image analysis for breast cancer detection and therapy planning, an adjacent radiology AI application sharing similar technology and customer base with Qlarity Imaging.

Broad incumbents

  • GE HealthCare: GE HealthCare's Edison platform bundles radiology AI capabilities with its installed base of imaging equipment and PACS, representing the broad incumbent that competes with and often acquires smaller radiology AI vendors.
  • Philips (IntelliSpace AI): Philips offers IntelliSpace AI and a portfolio of clinically validated radiology algorithms integrated into its imaging and PACS ecosystem, a broad incumbent peer with overlapping capability in AI-enhanced radiology workflows.
  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers' AI-Rad Companion offers AI-driven image analysis across multiple modalities integrated with their imaging fleet, representing a broad incumbent that competes in the same radiology AI segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

Qlarity Imaging social profiles

Digital presence

Qlarity Imaging financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qlarity Imaging leadership team

Management profile

Number of profiles

Profiles2 records

Qlarity Imaging funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qlarity Imaging M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qlarity Imaging

What does Qlarity Imaging do?

Qlarity Imaging develops artificial intelligence software aimed at improving patient care by enhancing the diagnostic insights available to radiologists. The company's offering centers on AI-driven analysis of medical images to support radiology workflows and clinical decision-making.

When was Qlarity Imaging founded?

Qlarity Imaging was founded in 2019. It employs 1 to 10 people.

Where is Qlarity Imaging based?

Qlarity Imaging is headquartered in Chicago, United States, in the North America region.

Who are Qlarity Imaging's main competitors?

Direct peers on record are Aidoc, Viz.ai, Zebra Medical Vision (Nanox AI), Riverain Technologies, Blackford Analysis and Arterys (Tempus). iCAD is listed as an emerging player. Broad incumbents are GE HealthCare, Philips (IntelliSpace AI) and Siemens Healthineers (AI-Rad Companion).

Does Qlarity Imaging have an API?

No public API is recorded for Qlarity Imaging.

What industry is Qlarity Imaging in?

Qlarity Imaging's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceQlarity Imaging and Blackford Partner to Bring QuantX™ Diagnostic AI to More Breast Radiologists via Blackford Platform™, Helping More Patients in NeedQlarity Imaging and Blackford announced an agreement to integrate QuantX diagnostic AI into Blackford's curated marketplace for breast MRI interpretation. The partnership aims to improve diagnostic accuracy and reduce workflow burdens for radiologists. QuantX is pending FDA clearance and has shown a 39% reduction in missed cancers in its De Novo trial.PR NewswireQlarity Imaging and Blackford Partner to Bring QuantX™ Diagnostic AI to More Breast Radiologists via Blackford Platform™, Helping More Patients in NeedQlarity Imaging and Blackford announced a partnership to integrate QuantX™, an AI diagnostic software for breast MRI interpretation, into Blackford’s curated medical imaging platform marketplace. The cloud-based, vendor-neutral version of QuantX™ is currently in development and pending FDA clearance, with the partnership aiming to reduce deployment costs, improve workflow efficiencies, and enhance diagnostic accuracy for radiologists and health systems. Both companies will be exhibiting at the AHRA 2021 Annual Meeting in Nashville.PR NewswireJon DeVries Named Qlarity Imaging Chief Executive OfficerParagon Biosciences appointed Jon T. DeVries as the new chief executive officer of its portfolio company, Qlarity Imaging. DeVries brings over 20 years of experience in medical imaging and AI to lead the company's mission of advancing breast cancer diagnosis through its FDA-cleared QuantX technology.PR NewswireQuantX Artificial Intelligence (AI) Breast Cancer Diagnosis System Receives 2020 Gold Edison AwardQlarity Imaging announced that its QuantX breast cancer diagnosis system received a 2020 Gold Edison Award in the Medical category, with the award selected by over 3,000 leading business executives worldwide. QuantX is the first-ever FDA-cleared computer-aided breast cancer diagnosis system for radiology and was previously named one of TIME magazine's best inventions of 2019. The system has demonstrated 20% greater accuracy in helping radiologists detect breast cancer compared to other available technologies.FierceBiotechParagon's new company to carry its AI-powered breast cancer diagnostic buyLife sciences incubator Paragon Biosciences has established a new portfolio company, Qlarity Imaging, to commercialize the FDA-cleared AI diagnostic platform QuantX. This spin-off aims to expand the technology's capabilities in breast cancer detection and pursue further venture financing. The initiative leverages research originally developed at the University of Chicago to enhance radiological diagnostic accuracy.